At least 102 health workers had been infected and 25 had died by July 1 in the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo and Uganda, with the first known case also a health worker.
Early protection gaps helped drive that toll: nurses reported shortages of masks, face shields, gowns, testing kits and equipment for handling remains, while infection-control readiness averaged 38.8% in assessed North Kivu facilities.
Response capacity has improved but remains strained, with contact-tracing follow-up rising from about 45% early in the outbreak to 81.3% by late June, still below WHO's 90% target.
International support has scaled up under a $518 million Africa CDC-WHO plan, backed by $220.6 million from the Pandemic Fund, as MSF runs three treatment centers and US CDC has about 400 staff on the response.
The outbreak underscores broader vulnerabilities in conflict-hit eastern DRC, where overcrowded treatment units, weak staffing and mistrust can expose caregivers first even as US importation risk remains low.
With no vaccine in a conflict zone, how can health workers stop the fastest-growing Ebola outbreak on record?
As a new Ebola strain rages, can scientists deliver a cure before the health system completely collapses?
Why are nations imposing travel bans that could worsen the crisis if the global risk is officially low?
Bundibugyo Ebola Outbreak 2026: Rapid Escalation, Systemic Gaps, and the Urgent Need for Targeted Vaccines
Overview
As of July 2026, the CDC is responding to a challenging Ebola outbreak caused by the Bundibugyo virus, mainly affecting remote areas in the Democratic Republic of the Congo and Uganda. Efforts to contain the virus face major hurdles, with only 32 percent of new cases identified through contact tracing—far below the target of over 90 percent. This low rate shows that the outbreak is outpacing response efforts, making it difficult to control the spread. The situation highlights the urgent need for better resources and strategies to manage the crisis effectively.